Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
Blood Advances|July 24, 2025
HLA-E[pHLA-G] Complex Specific Monoclonal Antibody Enhancing NK Activity in Multiple MyelomaMuhammad Abu Ahmad, Olga Radinsky, Bar Kaufman, et al.
Oncotarget|November 19, 2016
An NK cell line (haNK) expressing high levels of granzyme and engineered to express the high affinity CD16 alleleCaroline Jochems, James W Hodge, Massimo Fantini, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 29, 2019
Phase II Study of the PD-1 Inhibitor Pembrolizumab for the Treatment of Relapsed or Refractory Mature T-cell LymphomaStefan K Barta, Jasmine Zain, Alexander W MacFarlane, et al.
Cancer Discovery|January 8, 2024
Targeting DHX9 Triggers Tumor-Intrinsic Interferon Response and Replication Stress in Small Cell Lung CancerTakahiko Murayama, Jun Nakayama, Xinpei Jiang, et al.
Frontiers in Oncology|February 28, 2022
Tumor-Infiltrating Myeloid Cells Co-Express TREM1 and TREM2 and Elevated TREM-1 Associates With Disease Progression in Renal Cell CarcinomaJill W Ford, Marieli Gonzalez-Cotto, Alexander W MacFarlane, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 7, 2010
Altered gene expression in morphologically normal epithelial cells from heterozygous carriers of BRCA1 or BRCA2 mutationsAlfonso Bellacosa, Andrew K Godwin, Suraj Peri, et al.
The Journal of Clinical Investigation|March 14, 2018
Dose intensification of TRAIL-inducing ONC201 inhibits metastasis and promotes intratumoral NK cell recruitmentJessica Wagner, C Leah Kline, Lanlan Zhou, et al.
Cancer Biology & Therapy|January 22, 2005
Altered gene expression in phenotypically normal renal cells from carriers of tumor suppressor gene mutationsRadka Stoyanova, Margie L Clapper, Alfonso Bellacosa, et al.
Pageof 9